ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PALI Palisade Bio Inc

6.1745
-0.2855 (-4.42%)
Last Updated: 16:29:48
Delayed by 15 minutes
Share Name Share Symbol Market Type
Palisade Bio Inc NASDAQ:PALI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.2855 -4.42% 6.1745 6.10 6.37 6.42 5.94 6.42 19,382 16:29:48

Palisade Bio to Participate in the Virtual Investor Lunch Break Event

11/04/2024 2:15pm

GlobeNewswire Inc.


Palisade Bio (NASDAQ:PALI)
Historical Stock Chart


From Mar 2024 to May 2024

Click Here for more Palisade Bio Charts.

Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it will present at the Virtual Investor Lunch Break Featuring Palisade Bio event on Tuesday, April 16, 2024 at 12:00 PM ET.

As part of the event, J.D. Finley, Chief Executive Officer and Dr. Mitch Jones, Chief Medical Officer of Palisade Bio, will provide a corporate overview, business outlook, and discuss the Palisade Bio opportunity.

A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (www.palisadebio.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

About Palisade Bio Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.

Investor Relations ContactJTC Team, LLCJenene Thomas 833-475-8247PALI@jtcir.com

1 Year Palisade Bio Chart

1 Year Palisade Bio Chart

1 Month Palisade Bio Chart

1 Month Palisade Bio Chart

Your Recent History

Delayed Upgrade Clock